Publication: Efficacy, Safety and Tolerability of Natalizumab in Turkish Multiple Sclerosis Patients with High Disease Activity: A Prospective, Multicentre Study
| dc.authorwosid | Terzi̇, Murat/Aaa-1284-2021 | |
| dc.authorwosid | Soysal, Aysun/Aax-7696-2021 | |
| dc.authorwosid | Petek Balcı, Belgin/Cag-6344-2022 | |
| dc.authorwosid | Tütüncü, Melih/Aaf-1702-2021 | |
| dc.authorwosid | Türkoğlu, Recai/B-9336-2014 | |
| dc.authorwosid | Eraksoy, Mefkure/Aae-4872-2020 | |
| dc.authorwosid | Günal, Dilek/Aab-3508-2021 | |
| dc.contributor.author | Eraksoy, M. | |
| dc.contributor.author | Akman-Demir, G. | |
| dc.contributor.author | Agan, K. | |
| dc.contributor.author | Gunal, D. | |
| dc.contributor.author | Us, O. | |
| dc.contributor.author | Saip, S. | |
| dc.contributor.author | Siva, A. | |
| dc.contributor.authorID | Siva, Aksel/0000-0002-8340-6641 | |
| dc.contributor.authorID | Turkoglu, Recai/0000-0001-9724-851X | |
| dc.date.accessioned | 2025-12-11T01:22:03Z | |
| dc.date.issued | 2009 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Eraksoy, M.; Akman-Demir, G.; Dib, H.] Istanbul Fac Med, Istanbul, Turkey; [Agan, K.; Gunal, D.; Us, O.] Marmara Univ, Istanbul, Turkey; [Saip, S.; Demirci, N. O.; Tutuncu, M.; Siva, A.] Istanbul Univ, Istanbul, Turkey; [Turan, O. F.] Uludag Univ, Istanbul, Turkey; [Taskapilioglu, O.] Uludag Univ, Bursa, Turkey; [Boz, C.] Black Sea Univ, Trabzon, Turkey; [Terzi, M.; Onar, M.] 19th May Univ, Samsun, Turkey; [Aydin-Gungor, H.] Mediterrenean Univ, Antalya, Turkey; [Turk-Boru, U.] Dr Lutfi Kirdar Educ & Res Hosp, Istanbul, Turkey; [Soysal, A.] Sadi Konuk Educ & Res Hosp, Istanbul, Turkey; [Petek-Balci, B.] Haseki Res & Educ Hosp, Istanbul, Turkey | en_US |
| dc.description | Siva, Aksel/0000-0002-8340-6641; Turkoglu, Recai/0000-0001-9724-851X; | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Conference Proceedings Citation Index - Science | |
| dc.identifier.doi | 10.1016/S0022-510X(09)70798-1 | |
| dc.identifier.endpage | S209 | en_US |
| dc.identifier.issn | 0022-510X | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | S209 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/S0022-510X(09)70798-1 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/43290 | |
| dc.identifier.volume | 285 | en_US |
| dc.identifier.wos | WOS:000272521300731 | |
| dc.identifier.wosquality | Q2 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science Bv | en_US |
| dc.relation.ispartof | Journal of the Neurological Sciences | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Efficacy, Safety and Tolerability of Natalizumab in Turkish Multiple Sclerosis Patients with High Disease Activity: A Prospective, Multicentre Study | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
